Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: Assessment of 987 Hospitals

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 357-364

  Merkow, Ryan P ^a,b   Bilimoria, Karl Y ^c   McCarter, Martin D ^b   Chow, Warren B ^d   Ko, Clifford Y ^d   Bentrem, David J ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; GEOGRAPHY; HISTOLOGY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIMODALITY CANCER THERAPY; MULTIPLE LINEAR REGRESSION ANALYSIS; OUTCOME ASSESSMENT; RISK; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY; UNITED STATES;

AGED; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84856654554     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1945-3     Document Type: Article

References (40)

1. H Pohl HG Welch 2005 The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst. 97 142 146 15657344 10.1093/jnci/dji024
2. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
3. EF Courrech Staal BM Aleman H Boot, et al. 2010 Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer Br J Surg. 97 1482 1496 20645400 10.1002/bjs.7175 1:STN:280:DC%2BC3cfgt1GhtQ%3D%3D
4. TW Rice VW Rusch C Apperson-Hansen, et al. 2009 Worldwide esophageal cancer collaboration Dis Esophagus. 22 1 8 19196264 10.1111/j.1442-2050.2008. 00901.x 1:STN:280:DC%2BD1M7itFyiug%3D%3D
5. HJ Stein M Feith BL Bruecher, et al. 2005 Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection Ann Surg. 242 566 573 16192817
6. BH Burmeister BM Smithers V Gebski, et al. 2005 Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol. 6 659 668 16129366 10.1016/S1470-2045(05)70288-6
7. D Cunningham WH Allum SP Stenning, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med. 355 11 20 16822992 10.1056/NEJMoa055531 1:CAS:528:DC%2BD28Xms1Chsrw%3D
8. F Fiorica D Di Bona F Schepis, et al. 2004 Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut. 53 925 930 15194636 10.1136/gut.2003.025080 1:STN:280:DC%2BD2czitVCksA%3D%3D
9. V Gebski B Burmeister BM Smithers, et al. 2007 Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol. 8 226 234 17329193 10.1016/S1470-2045(07)70039-6 1:CAS:528:DC%2BD2sXisVCqs78%3D
10. SE Greer PP Goodney JE Sutton, et al. 2005 Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis Surgery. 137 172 177 15674197 10.1016/j.surg.2004.06.033
11. HL Jin H Zhu TS Ling, et al. 2009 Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis World J Gastroenterol. 15 5983 5991 20014464 10.3748/wjg.15.5983
12. IG Kaklamanos GR Walker K Ferry, et al. 2003 Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials Ann Surg Oncol. 10 754 761 12900366 10.1245/ASO.2003.03.078
13. DP Kelsen R Ginsberg TF Pajak, et al. 1998 Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med. 339 1979 1984 9869669 10.1056/NEJM199812313392704 1:STN:280: DyaK1M%2FnslCjsg%3D%3D
14. RA Malthaner RK Wong RB Rumble, et al. 2004 Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis BMC Med 2 35 15447788 10.1186/1741-7015-2-35
15. S Natsugoe H Okumura M Matsumoto, et al. 2006 Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution Dis Esophagus. 19 468 472 17069590 10.1111/j.1442-2050.2006.00615.x 1:STN:280:DC%2BD28njsVWqsQ%3D%3D
16. J Tepper MJ Krasna D Niedzwiecki, et al. 2008 Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol. 26 1086 1092 18309943 10.1200/JCO.2007.12.9593 1:CAS:528:DC%2BD1cXktVKitr0%3D
17. SG Urba MB Orringer A Turrisi, et al. 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol. 19 305 313 11208820 1:CAS:528: DC%2BD3MXhtVektrs%3D
18. JD Urschel H Vasan 2003 A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg. 185 538 543 12781882 10.1016/S0002-9610(03)00066-7
19. TN Walsh N Noonan D Hollywood, et al. 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med. 335 462 467 8672151 10.1056/NEJM199608153350702 1:STN:280:DyaK283psF2juw%3D%3D
20. M Ychou V Boige JP Pignon, et al. 2011 Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol. 29 1715 1721 21444866 10.1200/JCO.2010.33.0597 1:CAS:528:DC%2BC3MXnslCjt7w%3D
21. National Comprehensive Cancer Network Guidelines in Oncology. Esophageal cancer. Available at: http://www.nccn.org. Accessed January 15, 2010.
22. M Stahl W Budach HJ Meyer, et al. 2010 Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 v46 v49 20555101 10.1093/annonc/mdq163
23. Agency for Healthcare Research and Quality. Preoperative or postoperative therapy for resectable esophageal cancer: guideline recommendations. Available at: http://www.guideline.gov. Accessed January 15, 2010.
24. CK Enestvedt KA Perry C Kim, et al. 2010 Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons Dis Esophagus. 23 136 144 19515189 10.1111/j.1442-2050.2009. 00985.x 1:STN:280:DC%2BC3czhsFalsQ%3D%3D
25. Society for Surgery of the Alimentary Tract. Surgical treatment of esophageal cancer. Available at: http://www.ssat.com/cgi-bin/esoph.cgi. Accessed January 17, 2011.
26. Fogh SE, Yu A, Kubicek GJ, et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy? Int J Radiat Oncol Biol Phys. 2011;80:1372-6.
27. National Cancer Data Base. Available at: http://www.facs.org/cancer/ncdb/ index.html. Accessed October 1, 2010.
28. KY Bilimoria AK Stewart DP Winchester, et al. 2008 The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol. 15 683 690 18183467 10.1245/s10434-007-9747-3
29. Commission on Cancer. Cancer program accreditation. Available at: http://www.facs.org/cancer/coc/whatis.html. Accessed September 15, 2010.
30. AJCC Cancer Staging Manual. 6th ed. Chicago IL: Springer; 2002.
31. Department of Health, Human Services. The international classification of diseases. 9th revised clinical modification: ICD-9-CM. Washington, DC: Government Printing Office; 1998.
32. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol. 45 613 619 1607900 10.1016/0895-4356(92)90133-8 1:STN:280:DyaK38zgtVeqsA%3D%3D
33. ME Charlson P Pompei KL Ales, et al. 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis. 40 373 383 3558716 10.1016/0021-9681(87)90171-8 1:STN:280:DyaL2s7ms1GnsQ%3D%3D
34. Facility Oncology Registry Data Standards. Chicago, IL: Commission on Cancer; 2010.
35. JA Roth HI Pass MM Flanagan, et al. 1988 Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus J Thorac Cardiovasc Surg. 96 242 248 2456424 1:STN:280:DyaL1c3oslCktQ%3D%3D
36. WH Allum SP Stenning J Bancewicz, et al. 2009 Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol. 27 5062 5067 19770374 10.1200/JCO.2009.22.2083
37. Van Der Gaast A, van Hagen P, Hulshof M, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esopahageal or esophagograstic junction cancer: result from a multi-center randomized phase III study (abstract 4004). 2010 ASCO Annual Meeting, San Francisco.
38. Mariette C, Seitz JF, Maillard E, et al. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901 (abstract 4005). 2010 ASCO Annual Meeting, San Francisco.
39. JM Daly WA Fry AG Little, et al. 2000 Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation study J Am Coll Surg. 190 562 572 10801023 10.1016/S1072-7515(00)00238-6 1:STN:280:DC%2BD3c3lvV2lsw%3D%3D
40. EW Steyerberg B Neville JC Weeks, et al. 2007 Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients J Clin Oncol. 25 2389 2396 17557952 10.1200/JCO.2006.09.7931